Institutional investors purchased a net $1.1 million shares of NEO during the quarter ended December 2017, and now own 66.61% of the total float, a percentage that is typical for companies in the Medical/Nursing Services industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
HENDERSON GLOBAL INVESTORS LTD. Bought 5.6 Million shares of Neogenomics Inc
FIRST LIGHT ASSET MANAGEMENT LLC Bought 1.4 Million shares of Neogenomics Inc
FRANKLIN ADVISERS, INC. Bought 753.9 Thousand shares of Neogenomics Inc